Oscar Health

OSCR

Market cap $4.55B

In the closing of the recent trading day, Oscar Health, Inc. (OSCR) stood at $15.29, denoting a -1.23% move from the preceding trading day.

Oscar Health (OSCR 1.26%) stock is gaining momentum as investors grow less pessimistic about the industry.

Healthcare stocks are beaten down right now, but should provide durable value. UnitedHealth stock looks cheap and poised for a comeback.

Medicare's April 6 announcement that insurer payment rates are projected to rise by 2.48%, or over $13 billion, in 2027 looks like a bonanza for health insurers.

Oscar Health remains a "Buy" despite recent underperformance and a 7% stock drop since my last update. Management's 61% growth guidance sets high expectations; meeting it could drive positive price action and multiple expansion. Insider buying by the CEO boosts investor confidence in OSCR's outlook and execution.

The filing also showed Bertolini had 5.73 million performance stock units vest, with 1,000,001 shares withheld to satisfy tax obligations, but the clean read-through for traders is the open purchase from the company itself.

Investing legend Peter Lynch once noted that insiders sell for any number of reasons, but they buy for only one — they think the company's stock price will rise.

CMS said the changes are projected to result in a net average 2.48% increase, or more than $13 billion in additional Medicare Advantage payments for 2027, while also tightening how certain diagnoses are counted for risk adjustment.

NEW YORK--(BUSINESS WIRE)--Oscar Health, Inc. 2026 First Quarter Earnings Conference Call.

Oscar Health is an insurer rapidly gaining market share in the United States. The stock trades down on concerns about macro pressures, including a potential reduction in government subsidies.